Thus, to support the use of cholecalciferol as alternative adjuvant to alleviate muscle atrophy in patients with high levels of angiotensin II, future studies should assess the effects of cholecalciferol on counteracting angiotensin II‐induced muscle atrophy in vivo. This evidence concerns the gene AGT and Atrophy.